+39 02 610346.1 - info@newron.com

Latest press releases

  • 10Jan
    Seqirus and Zambon enter into a partnership for Parkinson’s disease product in Australia and New Zealand

  • 3Jan
    Evenamide met study objectives of good tolerability, safety, and preliminary evidence of efficacy as an add-on therapy for the treatment of schizophrenia- unique MoA

     

  • 23Dec
    Change in Newron’s Senior Management Team

     

  • 21Oct
    US FDA considers Newron’s re-submitted NDA for Xadago® to be a complete, class 2 response to Complete Response Letter PDUFA date March 21, 2017

     

  • 7Oct
    Newron raises CHF26.1 Mio. in a private placement of new shares

     

  • 7Oct
    Newron raises CHF26.1 Mio. in a private placement of new shares

     

View All

Newron share price

Events

  • 13Feb
    BIO CEO & Investor Conference 2017

    February 13-14, 2017 - New York, NY, USA

  • 9Jan
    J.P. Morgan 35th Annual Healthcare Conference 2017

    January 9-13 2017 - Los Angeles, LA, USA

  • 29Nov
    28th Annual Piper Jaffray Healthcare Conference

    November 29 and 30, 2016 - The Lotte New York Palace, New York - USA

View Event Calendar